Answers are grounded in this paper and cite their sources.
Hippocampal molecular responses to intracerebroventricular streptozotocin (ICV-STZ) may vary with time after treatment. We profiled hippocampal small RNAs by sequencing and proteins by label-free LC–MS/MS in male Wistar rats three and six weeks after bilateral ICV-STZ or vehicle (four animals per treatment–time group) and tested 12 of the same animals in the T-maze and novel-object-recognition tasks, using time-matched controls and animal-level linkage of the three datasets. At three weeks, 28 of 697 tested miRNA features (23 annotated miRNAs and five predicted candidate sequences) and 142 of 4243 protein groups met the within-contrast Benjamini–Hochberg threshold of q < 0.05; differential proteins included complement-, glial-, metabolic- and synapse-associated candidates whose cellular origin cannot be resolved in bulk tissue. No feature met the primary six-week threshold, although complete-case and variance-moderated protein analyses detected one and 19 protein groups. Twenty-one protein groups, but no miRNAs, showed treatment-by-time interactions. Three-week behavioural differences were compatible with impairment but did not pass Holm adjustment (both p = 0.090). Selected miRNA and protein profiles co-varied across animals (RV = 0.59, p = 0.0008) through the shared treatment effect, with no residual within-group coupling. These results nominate three-week candidates for independent validation while leaving persistence, cellular origin and functional consequences unresolved.
No takes yet. Share an insight, caveat, or question.
Yadikar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: